Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Current Deferred Revenue (2016 - 2026)

Kewaunee Scientific has reported Current Deferred Revenue over the past 16 years, most recently at $4.1 million for Q1 2026.

  • Quarterly results put Current Deferred Revenue at $4.1 million for Q1 2026, down 47.68% from a year ago — trailing twelve months through Jan 2026 was $4.1 million (down 47.68% YoY), and the annual figure for FY2025 was $6.1 million, up 38.84%.
  • Current Deferred Revenue for Q1 2026 was $4.1 million at Kewaunee Scientific, down from $4.3 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for KEQU hit a ceiling of $14.1 million in Q3 2022 and a floor of $3.1 million in Q1 2022.
  • Median Current Deferred Revenue over the past 5 years was $5.0 million (2025), compared with a mean of $6.3 million.
  • Biggest five-year swings in Current Deferred Revenue: surged 452.49% in 2022 and later plummeted 56.84% in 2023.
  • Kewaunee Scientific's Current Deferred Revenue stood at $11.4 million in 2022, then plummeted by 56.84% to $4.9 million in 2023, then increased by 26.83% to $6.2 million in 2024, then crashed by 30.41% to $4.3 million in 2025, then decreased by 6.33% to $4.1 million in 2026.
  • The last three reported values for Current Deferred Revenue were $4.1 million (Q1 2026), $4.3 million (Q4 2025), and $5.0 million (Q3 2025) per Business Quant data.